Vaxxinity, Inc. (VAXX)
NASDAQ: VAXX · IEX Real-Time Price · USD
4.42
0.33 (8.07%)
May 20, 2022 4:00 PM EDT - Market closed
Ratios and Metrics (Trailing)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Period Ended | Current | 2022-03-31 | 2021-12-31 |
|---|---|---|---|
| Market Capitalization | 557 | 541 | 703 |
| Enterprise Value | 443 | 427 | 569 |
| PE Ratio | - | -4.37 | -5.13 |
| PS Ratio | 8.00 | 11.00 | 10.00 |
| PB Ratio | 4.94 | 4.80 | 5.47 |
| EV/Sales Ratio | 6.00 | 8.00 | 9.00 |
| Debt / Equity Ratio | 0.09 | 0.09 | 0.08 |
| Debt / EBITDA Ratio | - | - | -0.08 |
| Debt / FCF Ratio | - | - | -0.13 |
| Current Ratio | 5.46 | 5.46 | 5.61 |
| Asset Turnover | - | 0 | 0.00 |
| Return on Equity (ROE) | - | 854.80% | -665.20% |
| Return on Assets (ROA) | -83.80% | -83.80% | -126.50% |
| Return on Capital (ROIC) | -1062.50% | -1062.50% | -579.70% |
| Earnings Yield | -22.16% | -22.87% | -19.50% |
| FCF Yield | - | - | -11.70% |
| Buyback Yield / Dilution | -83.38% | -83.38% | -16.68% |
| Total Shareholder Return | -83.38% | -83.38% | -16.68% |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).